Kozaczka A, Kamińska-Budzińska G, Machalski M, Ścieszka M. Cytoprotective drugs in cancer chemotherapy. Contemporary Oncology/Współczesna Onkologia. 2001;5(2):62-69.
APA
Kozaczka, A., Kamińska-Budzińska, G., Machalski, M., & Ścieszka, M. (2001). Cytoprotective drugs in cancer chemotherapy. Contemporary Oncology/Współczesna Onkologia, 5(2), 62-69.
Chicago
Kozaczka, Anna, Grażyna Kamińska-Budzińska, Marek Machalski, and Maria Ścieszka. 2001. "Cytoprotective drugs in cancer chemotherapy". Contemporary Oncology/Współczesna Onkologia 5 (2): 62-69.
Harvard
Kozaczka, A., Kamińska-Budzińska, G., Machalski, M., and Ścieszka, M. (2001). Cytoprotective drugs in cancer chemotherapy. Contemporary Oncology/Współczesna Onkologia, 5(2), pp.62-69.
MLA
Kozaczka, Anna et al. "Cytoprotective drugs in cancer chemotherapy." Contemporary Oncology/Współczesna Onkologia, vol. 5, no. 2, 2001, pp. 62-69.
Vancouver
Kozaczka A, Kamińska-Budzińska G, Machalski M, Ścieszka M. Cytoprotective drugs in cancer chemotherapy. Contemporary Oncology/Współczesna Onkologia. 2001;5(2):62-69.
The basic problems of chemotherapy of neoplastic diseases still are harmful side effects on various organ cells. In this article we discuss the most commonly used cytoprotecive drugs diminishing toxic effects of popular cytostatics. The promising role seems to have: amifostine, dexrazoxane, mesna and silibinin.